These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 17668337)
41. [What do intravenous drug users think about hepatitis?]. Grimnes G Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2164-6. PubMed ID: 16138126 [TBL] [Abstract][Full Text] [Related]
42. Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis. McMahon JM; Pouget ER; Tortu S J Infect Dis; 2007 Jun; 195(11):1572-81. PubMed ID: 17471426 [TBL] [Abstract][Full Text] [Related]
43. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore. Winslow M; Subramaniam M; Ng WL; Lee A; Song G; Chan YH Singapore Med J; 2007 Jun; 48(6):504-8. PubMed ID: 17538746 [TBL] [Abstract][Full Text] [Related]
44. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. Vicknasingam B; Narayanan S; Navaratnam V Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801 [TBL] [Abstract][Full Text] [Related]
45. The Thai HIV/AIDS epidemic at 15 years: sustained needle sharing among southern Thai drug injectors. Perngmark P; Vanichseni S; Celentano DD Drug Alcohol Depend; 2008 Jan; 92(1-3):183-90. PubMed ID: 17870252 [TBL] [Abstract][Full Text] [Related]
46. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience. Roy E; Boudreau JF; Boivin JF Drug Alcohol Depend; 2009 Jun; 102(1-3):158-61. PubMed ID: 19251382 [TBL] [Abstract][Full Text] [Related]
47. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. Hahn JA; Page-Shafer K; Lum PJ; Bourgois P; Stein E; Evans JL; Busch MP; Tobler LH; Phelps B; Moss AR J Infect Dis; 2002 Dec; 186(11):1558-64. PubMed ID: 12447730 [TBL] [Abstract][Full Text] [Related]
48. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. Oliveira ML; Yoshida CF; Telles PR; Hacker MA; Oliveira SA; Miguel JC; do O KM; Bastos FI Epidemiol Infect; 2009 Jul; 137(7):970-9. PubMed ID: 19144250 [TBL] [Abstract][Full Text] [Related]
49. Buprenorphine injection in Melbourne, Australia--an update. Aitken CK; Higgs PG; Hellard ME Drug Alcohol Rev; 2008 Mar; 27(2):197-9. PubMed ID: 18264882 [TBL] [Abstract][Full Text] [Related]
50. Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. Vickerman P; Hickman M; Judd A Int J Epidemiol; 2007 Apr; 36(2):396-405. PubMed ID: 17218325 [TBL] [Abstract][Full Text] [Related]
51. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888 [TBL] [Abstract][Full Text] [Related]
52. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Hagan H; Campbell J; Thiede H; Strathdee S; Ouellet L; Kapadia F; Hudson S; Garfein RS Public Health Rep; 2006; 121(6):710-9. PubMed ID: 17278406 [TBL] [Abstract][Full Text] [Related]
53. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. Garfein RS; Golub ET; Greenberg AE; Hagan H; Hanson DL; Hudson SM; Kapadia F; Latka MH; Ouellet LJ; Purcell DW; Strathdee SA; Thiede H; AIDS; 2007 Sep; 21(14):1923-32. PubMed ID: 17721100 [TBL] [Abstract][Full Text] [Related]
54. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors. Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918 [TBL] [Abstract][Full Text] [Related]
55. Correlates of receptive and distributive needle sharing among injection drug users in Kabul, Afghanistan. Todd CS; Abed AM; Scott PT; Botros BA; Safi N; Earhart KC; Strathdee SA Am J Drug Alcohol Abuse; 2008; 34(1):91-100. PubMed ID: 18161647 [TBL] [Abstract][Full Text] [Related]
56. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada. Shaw SY; Shah L; Jolly AM; Wylie JL Addiction; 2007 Oct; 102(10):1626-35. PubMed ID: 17854339 [TBL] [Abstract][Full Text] [Related]
57. Recipient syringe sharing and its relationship to social proximity, perception of risk and preparedness to share. Smyth BP; Roche A Addict Behav; 2007 Sep; 32(9):1943-8. PubMed ID: 17258399 [TBL] [Abstract][Full Text] [Related]
58. Epidemiological aspects of hepatitis C virus infection among HIV-infected individuals in Mato Grosso State, Central Brazil. Mussi AD; Pereira RA; CorrĂȘa e Silva Vde A; Martins RM; Souto FJ Acta Trop; 2007; 104(2-3):116-21. PubMed ID: 17888391 [TBL] [Abstract][Full Text] [Related]
59. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. De P; Cox J; Boivin JF; Platt RW; Jolly AM Addiction; 2007 Nov; 102(11):1730-9. PubMed ID: 17935581 [TBL] [Abstract][Full Text] [Related]
60. "The first shot": the context of first injection of illicit drugs, ongoing injecting practices, and hepatitis C infection in Rio de Janeiro, Brazil. Oliveira ML; Hacker MA; Oliveira SA; Telles PR; O KM; Yoshida CF; Bastos FI Cad Saude Publica; 2006 Apr; 22(4):861-70. PubMed ID: 16612439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]